MarketInOut Stock Screener Log In | Sign Up
 

iX Biopharma Ltd

SES • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 08/24/2026 17:11
iX Biopharma Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeSES
Market Capitalization546.66 mln
Float621 mln
Earnings Date08/24/2026

Piotroski F-Score

5 / 9
Neutral

Relative Strength

1 / 100
Severely lagging

Debt / Equity

0.35
Low leverage

ROE

-36.47
Deeply negative

Dividend Yield

0.00%
No dividend

DPS

0.00
No dividend

Business Description

iX Biopharma is a Singapore-based pharmaceutical and nutraceutical company that develops and sells treatments for pain, sexual health, mental health, metabolic conditions, and general wellness across Singapore, the United States, China, and Australia. The company is best known for its sublingual wafer technology, which delivers active ingredients through the lining of the mouth, and its product range spans both prescription medicines and consumer health supplements. Founded in 2004, iX Biopharma has several products already on the market and a broad pipeline of candidates at various stages of clinical development, including treatments for depression, obesity, diabetes, chronic pain, and respiratory illness.

Key Fundamentals

EPS-0.01
ROE-36.47
RPS0.00
ROIC-23.64
ROA-14.38
EBITDA, mln-1.97
EV / EBITDA-229
EV / EBIT-193
Revenue, mln3.83
EV / Revenue118

Financial Strength

Altman Z-Score21.35
Piotroski F-Score 5 / 9

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -14.43% 3 / 100   
1 Month 5.06% 85 / 100   
2 Months 12.16% 89 / 100   
6 Months 97.62% 98 / 100   
1 Year 1975% 100 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us